2015 VAM: 3101 - Urticaria: A Non-Allergic Disorder Treated as an Allergic Disorder
This recording addresses the conflicting evidence for the diagnosis and management of urticaria. These guidelines suggest that urticaria is not an allergic disease and that tests for allergy should not be performed. Instead they suggest that urticaria is an autoimmune disease although few tests for autoimmunity should be performed. This leaves the allergist without much ammunition for either diagnosis or management although omalizumab was recently approved as a treatment for urticaria. The recording explores these issues and how these conflicting pieces of evidence relate to each other.
AMA PRA Category 1 Credits™: 1.50
Credit must be claimed by June 30, 2017. Any credit request on or after July 1, 2017 will be subject to an administrative fee.
System requirements: Two most recent versions of Internet Explorer, Safari, Google Chrome, and Firefox
Allied Health Professionals
Upon completion of this activity, participants will be able to:
1. Discuss the urticaria guidelines
2. Identify and utilize the treatments appropriately, including anti-IgE
3. Identify the mechanisms of urticaria
Dr. Stephen C. Dreskin, MD PhD FAAAAI, University of Colorado Denver
Dr. Sarbjit S. Saini, MD FAAAAI, Department of Medicine, Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, MD
Prof. Marcus Maurer, MD, Department of Dermatology and Allergy, Charité – Universitätsmedizin, Berlin, Germany
- 1.50 AttendanceAttendance credit.
- 1.50 CECE credit.
- 1.50 CMECME credit.